BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5375748)

  • 1. Ultraviolet light cystoscopy in patients with bladder cancer. One year's experience.
    Sorensen BL; Barlebo H; Gammelgaard PA; Soeborg Ohlsen A
    Scand J Urol Nephrol; 1969; 3(3):193-200. PubMed ID: 5375748
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultraviolet cystoscopy in patients with bladder cancer.
    Whitmore WF; Bush IM
    Trans Am Assoc Genitourin Surg; 1965; 57():149-55. PubMed ID: 5855557
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultraviolet cystoscopy.
    Whitmore WF; Bush IM
    JAMA; 1968 Mar; 203(12):1057-9. PubMed ID: 5694368
    [No Abstract]   [Full Text] [Related]  

  • 4. The reliability of urinary cytology in the detection of tumours of urinary bladder.
    Mondal A; Banerjee DK
    J Indian Med Assoc; 1992 Oct; 90(10):265-7. PubMed ID: 1287085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of tetracycline fluorescence for the early diagnosis of malignant bladder neoplasms].
    Ziehen HP; Oswald K
    Z Urol Nephrol; 1970 Jul; 63(7):523-30. PubMed ID: 5476613
    [No Abstract]   [Full Text] [Related]  

  • 6. The localization of tetracycline microfluorescence in tumors of the urinary tract.
    Malis I; Cooper JF
    J Urol; 1968 Feb; 99(2):183-6. PubMed ID: 4170896
    [No Abstract]   [Full Text] [Related]  

  • 7. Occult cancer of the bladder. Its detection by ultraviolet tetracycline cystoscopy.
    Bush IM; Whitmore WF
    J Med Soc N J; 1967 Feb; 64(2):56-60. PubMed ID: 5231700
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinically occult bladder cancer diagnosis. Trial using ultraviolet cystoscopy.
    Devonec M; Lenz P; Bouvier R; Blanc-Brunat N; Dubernard JM
    Cancer; 1985 Jan; 55(2):468-71. PubMed ID: 2578087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reliability of urinary cytology for follow-up of bladder cancer].
    Ginesin Y; Malberger E; Semberg S; Levin DR
    Harefuah; 1987 Sep; 113(5-6):101-3. PubMed ID: 3692366
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
    Chuttiangtum A; Udomthavornsuk B; Chumworathayi B
    Asian Pac J Cancer Prev; 2012; 13(10):4931-3. PubMed ID: 23244084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
    Cariou G; Maaraoui N; Cortesse A
    Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine cytology as a screening test for bladder infiltration in cervical cancer.
    Snyman LC; Zondagh BA; Dreyer G; Lindeque BG; Louw M
    Int J Gynecol Cancer; 2006; 16(4):1587-90. PubMed ID: 16884370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of bladder carcinoma].
    Hofmann W
    Z Urol Nephrol; 1974 Mar; 67(3):227-9. PubMed ID: 4603468
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinoma in situ of the bladder in workers exposed to xenylamine: diagnosis by ultraviolet light cystoscopy.
    Melick WF; Naryka JJ
    J Urol; 1968 Feb; 99(2):178-82. PubMed ID: 5641074
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in the diagnosis of bladder carcinoma].
    Martínez-Piñeiro JA; González Martín M; Arocena Lanz F; Escudero A
    Rev Clin Esp; 1973 Nov; 131(4):273-84. PubMed ID: 4589592
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
    Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
    J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.